Full Text Journal Articles by
Author Kate Cuschieri

Advertisement

Find full text journal articles






FAM19A4/miR124-2 methylation testing and HPV16/18 genotyping in HPV-positive women under the age of 30 years.

Frederique J Vink, Chris J L M Meijer, Albertus T Hesselink, Arno N Floore, Birgit I Lissenberg-Witte, Jesper H Bonde, Helle Pedersen, Kate Cuschieri, Ramya Bhatia, Mario Poljak, Anja Oštrbenk Valenčak, Peter Hillemanns, Wim G V Quint, Marta Del Pino, Gemma G Kenter, Renske D M Steenbergen, Daniëlle A M Heideman, Maaike C G Bleeker,

<h4>Introduction</h4>HSIL or CIN2/3 lesions in HPV-positive women <30 years have high spontaneous regression rates. To reduce overtreatment, biomarkers are needed to delineate advanced CIN lesions that require treatment. We analysed the FAM19A4/miR124-2 methylation test and HPV16/18 genotyping in HPV-positive women <30 years aiming to identify CIN2/3 lesions in need of ... Read more >>

Clin Infect Dis (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America)
[2022, :ciac433]

Cited: 0 times

View full text PDF listing >>



Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data.

Matejka Rebolj, Kate Cuschieri, Christopher S Mathews, Francesca Pesola, Karin Denton, Henry Kitchener, ,

<h4>Objectives</h4>To provide updated evidence about the risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) and cervical cancer after a negative human papillomavirus (HPV) test in primary cervical screening, by age group and test assay.<h4>Design</h4>Observational study.<h4>Setting</h4>Real world data from the English HPV screening pilot's first and second rounds (2013-16, ... Read more >>

BMJ (BMJ (Clinical research ed.))
[2022, 377:e068776]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.5572 s